Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
May 3, 2019 • 2min
Drug Prices for Lambert Eaton Myasthenic Syndrome
Dr. Jason Crowell discusses skyrocketing costs of a drug used for treatment with Lambert-Eaton myasthenic syndrome.
May 2, 2019 • 1min
Medical Clerkships in Neurology
Dr. Rae Bacharach discusses trends in medical clerkships in neurology.
May 1, 2019 • 1min
Continuum Pearls: Early-onset Alzheimer Disease
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Continuum Dementia issue, discusses early-onset Alzheimer Disease. To learn more, read the article "Early-onset Alzheimer Disease and Its Variants" by Dr. Mario F. Mendez in that issue.
Apr 30, 2019 • 2min
Dr. Jenny Linnoila discusses: Mouse model of anti-NMDA receptor post–herpes simplex encephalitis
Dr. Jenny Linnoila discusses the main takeaways from her podcast interview and paper on a mouse model of anti-NMDA receptor post-herpes simplex encephalitis.
Apr 29, 2019 • 1min
Gene Editing and CRISPR
Pam Belluck of the New York Times discusses He Jiankui, gene editing and CRISPR. Read one of the articles on the issue here: https://www.nytimes.com/2019/04/14/health/gene-editing-babies.html
Apr 25, 2019 • 1min
New FDA-Approved Treatments for MS
Dr. Rae Bacharach discusses two new, disease-modifying therapies for use in multiple sclerosis.
Apr 24, 2019 • 1min
Continuum Pearls: Transient Epileptic Amnesia
Dr. Gregory Day discusses the recognition of transient epileptic amnesia. To learn more, read Dr. Day's article, "Reversible Dementias," in the February 2019 Dementia issue of Continuum.
Apr 23, 2019 • 1min
Montreal Cognitive Assessment as a screening tool: Influence of performance and symptom validity
Dr. Brigid Waldron-Perrine talks about the Montreal Cognitive Assessment as a screening tool.
Apr 22, 2019 • 2min
Use of Neurofilament Light as a Potential Biomarker for Alzheimer's Disease
Dr. Mathias Jucker discusses the use of neurofilament light as a potential biomarker for Alzheimer's Disease.
Apr 17, 2019 • 1min
Continuum Pearls: Behavioral Variant Frontotemporal Dementia
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses behavioral-variant frontotemporal dementia. To learn more, read the article "Behavioral Variant Frontotemporal Dementia" by Dr. William W. Seeley in that issue.
